Homes
Public Notices
News
Local news
Editor’s Pick
Pittsburgh
Local Government
Roads, Travel and Traffic
20 Years of Gas Drilling
Regional
U.S. and World
Business
Sports
HS Sports
College Sports
Penguins
Pirates
Steelers
Athlete of the Week
Wild Things
Pony Baseball
Outdoors
Columns
Opinion
Columns
Editorials
Letters to the Editor
Op Eds
Living
Neighbors
School News
Entertainment
Home and Garden
Food
Police Beat
Obituaries
Classifieds
Legal Notices
Jobs
Sponsored Content
e-Edition
close
Washington County
Greene County
Mon Valley
News
Local news
Police Beat
Pittsburgh
Local Government
Roads, Travel and Traffic
Helping The Helpers
20 Years of Gas Drilling
Regional
U.S. and World
Business News
Sports
High School Sports
College Sports
Penguins
Pirates
Steelers
Wild Things
Pro Sports
Outdoors
Sports Column
Obituaries
Opinion
Columns
Editorials
Letters to the Editor
Op-Ed
Living
Neighbors
Health and Wellness
Entertainment
Home and Garden
Classifieds
Jobs
Contact Us
Advertise With Us
Customer Service
Contact Information
Submission Forms
Statement of Values
Misc
Special Sections
Events
Sponsored Content
Newsletter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude+Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Revolution Medicines, Inc. - Common Stock
(NQ:
RVMD
)
151.56
-2.17 (-1.41%)
Streaming Delayed Price
Updated: 4:00 PM EDT, May 22, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Revolution Medicines, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
Next >
Cancer Player Revolution Medicines Gets Bullish Rating: Here's Details
↗
November 16, 2023
Raymond James initiated coverage on Revolution Medicines Inc (NASDAQ: RVMD), noting that the October readout of RMC-6236 was compelling compared to historical SoC.
Via
Benzinga
What 6 Analyst Ratings Have To Say About Revolution Medicines
↗
November 07, 2023
Via
Benzinga
Earnings Scheduled For November 6, 2023
↗
November 06, 2023
Companies Reporting Before The Bell • Kosmos Energy (NYSE:KOS) is expected to report quarterly earnings at $0.16 per share on revenue of $366.82 million.
Via
Benzinga
Preview: Revolution Medicines's Earnings
↗
November 03, 2023
Via
Benzinga
Crude Oil Falls Sharply; Apollomics Shares Plunge
↗
October 23, 2023
U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite gaining over 100 points on Monday. The Dow traded down 0.19% to 33,062.85 while the NASDAQ rose 0.80% to 13,088.09. The S&P...
Via
Benzinga
Topics
Stocks
12 Health Care Stocks Moving In Monday's Intraday Session
↗
October 23, 2023
Via
Benzinga
Why Revolution Medicines Stock Is Crashing Today
↗
October 23, 2023
Investors were disappointed by Revolution Medicines' data, presented at ESMO.
Via
The Motley Fool
Expert Ratings for Revolution Medicines
↗
October 12, 2023
Via
Benzinga
Stifel Maintains Buy Rating for Revolution Medicines: Here's What You Need To Know
↗
September 21, 2023
Via
Benzinga
Why EngageSmart Shares Are Trading Higher By Around 12%? Here Are Other Stocks Moving In Monday's Mid-Day Session
↗
October 23, 2023
Gainers INVO Bioscience, Inc. (NASDAQ: INVO) jumped 375% to $2.57 as the company agreed to acquire NAYA Biosciences in an all-stock transaction.
Via
Benzinga
Nasdaq Turns Higher; Akumin Shares Jump
↗
October 23, 2023
U.S. stocks pared losses midway through trading, with the Nasdaq Composite gaining over 60 points on Monday. The Dow traded down 0.01% to 33,126.50 while the NASDAQ rose 0.54% to 13,054.00. The S&P 500...
Via
Benzinga
Topics
Stocks
FMC, Li-Cycle Holdings, Okta And Other Big Stocks Moving Lower On Monday
↗
October 23, 2023
U.S. stocks traded slightly higher, with the Nasdaq Composite gaining around 10 points on Monday. Here are some big stocks recording losses in today’s session.
Via
Benzinga
Topics
Stocks
Analyst Ratings for Revolution Medicines
↗
August 09, 2023
Via
Benzinga
Revolution Medicines Earnings Preview
↗
August 07, 2023
Via
Benzinga
Revolution Medicines Crashes 39% On Lackluster Test Results In Cancer Treatment
↗
October 23, 2023
The results were "at best, in line" with expectations for lung and pancreatic cancer treatment.
Via
Investor's Business Daily
Dow Falls Over 100 Points; Chicago Fed National Activity Index Increases In September
↗
October 23, 2023
U.S. stocks traded lower this morning, with the Dow Jones index falling over 100 points on Monday. Following the market opening Monday, The Dow traded down 0.41% to 32,991.58 while the NASDAQ fell...
Via
Benzinga
Topics
Economy
Stocks
12 Health Care Stocks Moving In Monday's Pre-Market Session
↗
October 23, 2023
Via
Benzinga
Revolution Medicines Stock Joins Elite Club With RS Ratings Over 90
↗
October 16, 2023
Revolution Medicines shows improving price performance, earning an upgrade to its IBD Relative Strength Rating.
Via
Investor's Business Daily
Lululemon, PCTEL, Consolidated Communications, Other Stocks Jumping Higher On Monday
↗
October 16, 2023
U.S. stocks traded higher, with the Dow Jones gaining more than 350 points on Monday. Here are some stocks recording big gains in today’s session.
Via
Benzinga
Topics
Stocks
Why Shares of Revolution Medicines Were Popping on Friday
↗
October 13, 2023
The company released positive phase 1/1b trial data on two cancer therapies.
Via
The Motley Fool
Why Is Cancer Focused Revolution Medicines Stock Trading Higher Today?
↗
October 13, 2023
Revolution Medicines Inc (NASDAQ: RVMD) released preliminary data for RMC-6236, its RASMULTI(ON) Inhibitor, and RMC-6291, its RASG12C(ON) Inhibitor, from the
Via
Benzinga
Top 4 Health Care Stocks That Are Preparing To Pump This Quarter
↗
October 06, 2023
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.
Via
Benzinga
10 Health Care Stocks Whale Activity In Today's Session
↗
September 21, 2023
Via
Benzinga
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Capri Holdings Limited (NYSE – CPRI), Avid® (Nasdaq - AVID), EQRx, Inc. (Nasdaq - EQRX)
August 10, 2023
From
Brodsky & Smith LLC
Via
GlobeNewswire
Top 5 Health Care Stocks That May Crash In Q3
↗
August 07, 2023
The most overbought stocks in the health care sector presents an opportunity to go short on these overvalued companies.
Via
Benzinga
Why Aaron's Shares Are Trading Lower By Over 9%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
↗
August 01, 2023
Gainers Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) shares gained 188.8% to $4.13. The stock is now on the Regulation SHO "threshold security" list.
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
↗
August 01, 2023
Via
Benzinga
Revolution Medicines To Acquire EQRx In All-Stock Transaction To Gain Over $1B In Additional Capital
↗
August 01, 2023
Revolution Medicines Inc (NASDAQ: RVMD) has agreed to acquire EQRx Inc (NASDAQ: EQRX) in an all-stock transaction intended to add more than $1 billion in net cash to
Via
Benzinga
RVMD Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Revolution Medicines, Inc. Is Fair to Shareholders
August 01, 2023
From
Halper Sadeh LLC
Via
Business Wire
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
↗
August 01, 2023
Via
Benzinga
< Previous
1
2
3
4
5
6
7
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
Starting at $3.75
/
week.
Subscribe Today